1. Effects of infliximab on markers of inflammation and bone turnover and associations with bone mineral density in patients with ankylosing spondylitis. Issue 2 (21st May 2008) Authors: Visvanathan, S; van der Heijde, D; Deodhar, A; Wagner, C; Baker, D G; Han, J; Braun, J Journal: Annals of the rheumatic diseases Issue: Volume 68:Issue 2(2009) Page Start: 175 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Golimumab, a human antibody to tumour necrosis factor α given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study. Issue 6 (9th December 2008) Authors: Keystone, E C; Genovese, M C; Klareskog, L; Hsia, E C; Hall, S T; Miranda, P C; Pazdur, J; Bae, S-C; Palmer, W; Zrubek, J; Wiekowski, M; Visvanathan, S; Wu, Z; Rahman, M U Journal: Annals of the rheumatic diseases Issue: Volume 68:Issue 6(2009) Page Start: 789 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. IgG rheumatoid factor synthesis in synovial fluid. Issue 12 (December 1992) Authors: Visvanathan, S; Robertson, P W; Bertouch, J V Journal: Annals of the rheumatic diseases Issue: Volume 51:Issue 12(1992) Page Start: 1342 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Inflammatory biomarkers, disease activity and spinal disease measures in patients with ankylosing spondylitis after treatment with infliximab. Issue 4 (20th July 2007) Authors: Visvanathan, S; Wagner, C; Marini, J C; Baker, D; Gathany, T; Han, J; van der Heijde, D; Braun, J Journal: Annals of the rheumatic diseases Issue: Volume 67:Issue 4(2008) Page Start: 511 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗